Prognostic significance of newly defined ploidy related parameters in melanoma

Anticancer Research

Volumn 20, Issue 3 A, 2000, Pages 1685-1690

  Korabiowska, Monika ^a,b   Brinck, Ulrich ^a   Brinkmann, Uwe ^a   Berger, Hermann ^a   Ruschenburg, Ilka ^a   Droese, Manfred ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b Department of Cytopathology ^*  (Germany)

Author keywords

CAS200; Malignant melanoma; Ploidy

Indexed keywords

DNA;

ADULT; AGED; ANALYZER; ANEUPLOIDY; ARTICLE; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIVARIATE ANALYSIS; PLOIDY; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLOIDIES; PROGNOSIS; REGRESSION ANALYSIS; SURVIVAL ANALYSIS;

EID: 0033856513     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Itakura Y, Sasano H, Mori S and Nagura H: DNA ploidy in human esophageal squamous dysplasias and squamous cell carcinomas as determined by image analysis. Mod Pathol 7: 867-873, 1994.
2. Padberg BC, Arps H and Franke U: DNA cytophotometry and prognosis in ovarian tumors of borderline malignancy. A clinico-morphologic study of 80 cases. Cancer 69: 2510-2514, 1992.
3. Collin F, Chassevent A, Bonichon F, Bertrand G, Terrier P and Coindre JM: Flow cytometric DNA content analysis of 185 soft tissue neoplasms indicates that S-phase fraction is a prognostic factor for sarcomas. Cancer 79: 2371-2379, 1997.
4. Brinck U, Korabiowska M, Knapik J, Ruschenburg I, Bartkowski SB and Stachura J: Comparison of the DNA content in recurrent and nonrecurrent hasaliomas of the face. Pol J Pathol 49: 97-100, 1998.
5. Bosari S, Lee AKC, Wiley BD, Heatley GJ and Silverman ML: Flow cytometric and image analyses of colorectal adenocarcinomas: a comparative study with clinical correlations. Am J Clin Pathol 99: 187-194, 1993.
6. Korabiowska M, Meiser P, Hönig JF, Kellner S, Brinck U and Fischer G: Analysis of ploidy status in progression of head and neck cancers by DNA image cytometry. Oncology Rep 3: 1165-1168, 1996.
7. Korabiowska M, Brinck U, Ruschenburg I, Kellner S, Droese M and Berger H: Analysis of the DNA content in Bowen's disease. Int J Mol Med 1: 613-616, 1998.
8. Korabiowska M, Ruschenburg I, Brinck U, Jahns A, Berger H and Droese M: Comparison of ploidy status of melanoma metastases in different locations. Int J Mol Med 2: 113-116, 1998.
9. Korabiowska M, Berger H, Keci A, Nagel H, Ruschenburg I, Droese M and Brinck U: Comparison of the DNA content in the different steps of cutaneous carcinoma progression. In Vivo 1999 in press.
10. Auer GU, Casperson TO and Wallgrenas S: DNA content and survival in mammary carcinoma. Anal Quant Cytol 2: 161-165, 1980.
11. Kaplan EL and Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53: 457-460, 1958.
12. Kalbfleisch JD and Prentice RL: The statistical analysis of failure time data. 1st ed. New York: John Willey and Sons 1980.
13. Danque POV, Chen HB, Patil J, Jagirdar J, Orsatti G and Paronetto F: Image analysis versus flow cytometry for DNA ploidy quantitation of solid tumors: a comparison of six methods of sample preparations. Mod Pathol 6: 270-275, 1993.
14. Elsheikh TM, Silverman JF and McCool JW: Comparative DNA analysis of solid tumors by flow cytometric and image analyses of touch imprints anf flow cell suspensions. Am J Clin Pathol 98: 296-304, 1992.
15. Rode J, Williams RA, Charlton IG, Dhillon AP and Moss E: Nuclear DNA profiles in primary melanomas and their metastases. Cancer 67: 2333-2336, 1991.
16. Muhonen T, Pyrhonen S, Laasonen A, Wasenius VM, Asko-Seljavaara S, Franssila K and Kangas L: Tumour growth rate and DNA flow cytometry as prognostic factors in metastatic melanomas. Br J Cancer 66: 528-532, 1992.
17. Barlogie B, Drewinko B, Schumann J, Gohde W, Dosik G and Johnston DA: Cellular DNA content as a marker of neoplasia in man. Am J Med 69: 195-203, 1980.
18. Korabiowska M, Brinck U, Ruschenburg I, Kellner S, Droese M and Berger H: How can one explain aneuploidy status in fibromatous and lipomatous naevus cell naevus? Anticancer Res 19: 1193-1196, 1999.
19. Theodori L, Capurso L, Cordelli E, De Vita R, Koch M, Tarquini M, Pallone F and Mauro F: Cytometrically determined relative DNA content as an indicator of neoplasia in gastric lesions. Cytometry 5: 63-67, 1984.
20. Toti P, Greco G, Mangiavacchi P, Bruni A, Palmeri ML and Luzi P: DNA ploidy pattern in choroidal melanoma: correlation with survival. A flow cytometry study on archival material. Br J Opthalmol 82: 1433-1437, 1998.
21. Baldi G, Baldi F, Maguire M and Massaro-Giordano M: Prognostic factors for survival after enucleation for choroidal melanoma. Int J Oncol 13: 1185-1189, 1998.
22. Scheistroen M, Trope C, Kaern J, Abeler VM, Pettersen EO and Kristensen GB: Malignant melanoma of the vulva FIGO stage I: Evaluation of prognostic factors in 43 patients with emphasis on DNA ploidy and surgical treatment. Gynecol Oncol 61: 253-258, 1996.
23. Korabiowska M, Brinkmann U, Kellner S, Brinck U, Stachura J and Schauer A: Differences of ploidy status in progression of head and neck melanomas. Int J Oncol 10: 381-385, 1997.
24. Tralongo V, Daniele E, Leonardi V and Rodolico V: Prognostic value of clinicopathologic variables and DNA ploidy in stage I cutaneous malignant melanoma. Oncol Rep 5: 1095-1098, 1998.
25. Reddy VB, Gattuso P, Aranha P and Carson HJ: Cell proliferation markers in predicting metastases in malignant melanoma. J Cutan Pathol 22: 248-251, 1995.